Allen D. Howard

Allen D. Howard is executive chairman, managing member and co-founder of Throne Petroleum, an exploration and production company in Houston. Howard developed the proprietary technical and analytical approach used by the company to identify undervalued reservoirs.

Howard began his career in the energy industry serving in a range of sales and management roles with General Chemical, ESS Environmental Services, American Owned Inc. and Schlumberger. In 1991, he was part of the founding team of NUMAR Corporation, a leader in developing applications for nuclear magnetic resonance technology across the oil and gas industry. Howard served as vice president of technical and commercial development with NUMAR Corporation, which was acquired by Halliburton in 1997 in a Halliburton in a deal valued at $360 million. Howard continued in his role as vice president for Halliburton until 1998, when he founded NuTech Energy Alliance, a leading reservoir intelligence company serving the upstream oil and gas energy. Howard served as president and CEO of NuTech Energy Alliance until 2016.

Howard received a bachelor’s degree in electrical and electronics engineering from Texas Tech University where he has been recognized with both the Distinguished Engineer and Outstanding Electrical Engineer Alumni awards. He has served as president of the Edward E. Whitacre Jr. College of Engineering Dean’s Council, and continues to serve as a member of the Texas Tech Foundation. Active in his industry, he is a member of the Society of Petrophysicists and Well Log Analysts, the Society for Petroleum ENgineers and the National Association of Corporate Directors.

In 2010, Howard founded Autumn’s Dawn, a non-profit organization dedicated to helping young people with autism transition into adulthood. Autumn’s Dawn has partnered with Texas Tech University to create the NeuroImaging, Cognition and Engineering (NICE) Laboratory, where researchers use functional MRI and other technologies to better understand the brain characteristics of children and young adults with autism spectrum disorder.